AN2 Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The Company is focused on advancing its first product candidate, epetraborole, a once... Read more
MarketWatch
CNBC
CNBC
SeekingAlpha
Access detailed stock analysis from LSEG including analyst price target estimates.